Robert P. Schleimer

Robert P. Schleimer's AcademicInfluence.com Rankings

Robert P. Schleimer

Biology

#5264

World Rank

#7701

Historical Rank

Immunology

#242

World Rank

#252

Historical Rank

biology Degrees

Download Badge

Biology

Robert P. Schleimer's Degrees

PhD Immunology University of California, San Francisco
Doctorate Medicine University of California, San Francisco

Why Is Robert P. Schleimer Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert P. Schleimer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. (1992) (836)
Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules (1991) (677)
Activation of airway epithelial cells by toll-like receptor agonists. (2004) (490)
TLR3- and Th2 Cytokine-Dependent Production of Thymic Stromal Lymphopoietin in Human Airway Epithelial Cells1 (2007) (469)
Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. (2013) (462)
Prevalence and Severity of Food Allergies Among US Adults (2019) (441)
IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. (1995) (419)
Asthma outcomes: biomarkers. (2012) (359)
Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. (1986) (355)
Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. (2007) (328)
Epithelium: at the interface of innate and adaptive immune responses. (2007) (326)
Generation of leukotrienes by purified human lung mast cells. (1982) (292)
Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis. (2017) (288)
Atopic Dermatitis Is Associated with a Functional Mutation in the Promoter of the C-C Chemokine RANTES1 (2000) (287)
Perspectives on the Etiology of Chronic Rhinosinusitis: An Immune Barrier Hypothesis (2008) (275)
Eosinophils in health and disease: the LIAR hypothesis (2010) (274)
Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. (1995) (274)
Chronic Rhinosinusitis with Nasal Polyps. (2016) (272)
The role of adhesion molecules in human eosinophil and basophil recruitment. (1994) (241)
Chronic rhinosinusitis pathogenesis. (2015) (240)
Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. (1990) (236)
Arachidonic acid metabolism in purified human lung mast cells. (1984) (234)
Activation of Eotaxin Gene Transcription by NF-κB and STAT6 in Human Airway Epithelial Cells (1999) (233)
Neuropeptides activate human mast cell degranulation and chemokine production (2008) (230)
Filarial Nematode Parasites Secrete a Homologue of the Human Cytokine Macrophage Migration Inhibitory Factor (1998) (229)
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19 (2020) (224)
Human lung mast cells: purification and characterization. (1982) (224)
Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. (1983) (217)
Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration. (1992) (215)
Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. (2013) (197)
Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. (1995) (195)
Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease. (2015) (193)
Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. (1997) (193)
Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. (1984) (191)
The effects of glucocorticoids on human eosinophils. (1994) (188)
An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. (1989) (186)
Needs and opportunities for research in hypersensitivity pneumonitis. (2005) (184)
Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. (2001) (183)
Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. (1994) (181)
Inhibition of basophil histamine release by anti-inflammatory steroids (1981) (178)
Airway Epithelial Cells Produce B Cell-Activating Factor of TNF Family by an IFN-β-Dependent Mechanism1 (2006) (175)
Incidence and associated premorbid diagnoses of patients with chronic rhinosinusitis. (2013) (174)
Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment (2001) (174)
Neuropeptides activate human mast cell degranulation and chemokine production. (2006) (173)
Chemokines and allergic disease. (1999) (172)
Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils (1997) (171)
Pathogenesis of nasal polyposis (2015) (171)
Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. (1996) (168)
Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. (2008) (167)
Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. (1988) (165)
Phenotyping and cytokine regulation of the BEAS-2B human bronchial epithelial cell: demonstration of inducible expression of the adhesion molecules VCAM-1 and ICAM-1. (1997) (158)
Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. (2004) (157)
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. (1987) (156)
Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. (2009) (156)
Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma. (2008) (154)
Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model. (2009) (153)
The Etiology and Pathogenesis of Chronic Rhinosinusitis: a Review of Current Hypotheses (2015) (150)
Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. (1994) (150)
Association between Severity of Asthma and Degree of Chronic Rhinosinusitis (2011) (150)
Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. (2000) (150)
Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. (2002) (148)
Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells. (1988) (144)
Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis. (2019) (144)
Characterization of inflammatory mediator release from purified human lung mast cells. (1986) (143)
Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease. (2017) (141)
Nasal and sinus symptoms and chronic rhinosinusitis in a population‐based sample (2017) (140)
Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. (1989) (139)
Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes (2018) (138)
Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps. (2010) (137)
B-lymphocyte lineage cells and the respiratory system. (2013) (134)
Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. (1991) (133)
Recombinant IL-3 induces histamine release from human basophils. (1989) (133)
Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells. (2005) (133)
Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells. (2011) (133)
An overview of glucocorticoid anti-inflammatory actions (2005) (126)
Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. (1999) (125)
Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments. (1982) (122)
Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression. (2013) (121)
Anti-Inflammatory Steroid Action: Basic and Clinical Aspects (1989) (120)
A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome (2016) (120)
Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. (2011) (119)
Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. (1999) (119)
Genome-wide Association Study Identifies Peanut Allergy-Specific Loci and Evidence of Epigenetic Mediation in U.S. Children (2015) (119)
Role of human basophils and mast cells in the pathogenesis of allergic diseases. (1985) (118)
Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. (1991) (117)
Altered Expression of Genes Associated with Innate Immunity and Inflammation in Recalcitrant Rhinosinusitis with Polyps (2006) (117)
Cutaneous Injection of Human Subjects with Macrophage Inflammatory Protein-1α Induces Significant Recruitment of Neutrophils and Monocytes1 (2000) (115)
Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. (1992) (113)
Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases (2017) (113)
Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. (1991) (112)
Elevated CO2 selectively inhibits interleukin‐6 and tumor necrosis factor expression and decreases phagocytosis in the macrophage (2010) (112)
Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. (1992) (110)
Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois. (2017) (109)
Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines. (1994) (109)
Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps. (2012) (108)
Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin. (2012) (108)
Epithelium, inflammation, and immunity in the upper airways of humans: studies in chronic rhinosinusitis. (2009) (108)
Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. (1986) (107)
Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. (1996) (106)
Heterogeneity of human mast cells. (1983) (106)
A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS) (2016) (106)
Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine (2001) (106)
Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis. (2010) (104)
Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action. (1982) (104)
Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression. (2013) (103)
Comparative studies of human basophils and mast cells. (1983) (103)
Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects. (1997) (101)
Genome-wide association study identifies peanut allergy-specific loci and evidence of epigenetic mediation in US children (2015) (101)
Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps (2017) (100)
Interleukin-1 is released at sites of human cutaneous allergic reactions. (1990) (99)
Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids. (1999) (98)
IL-3 augments adhesiveness for endothelium and CD11b expression in human basophils but not neutrophils. (1990) (98)
Perspectives on the etiology of chronic rhinosinusitis (2010) (96)
CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils. (1998) (95)
Genetics of chronic rhinosinusitis: state of the field and directions forward. (2013) (95)
Atopic profile of patients failing medical therapy for chronic rhinosinusitis (2011) (94)
Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease. (2015) (94)
Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. (1989) (94)
Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. I. Characterization of the response. (1981) (94)
Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps. (2013) (93)
Lipopolysaccharide-induced leukocyte rolling and adhesion in the rat mesenteric microcirculation: regulation by glucocorticoids and role of cytokines. (1998) (91)
Evaluation of the Presence of B-cell attractant Chemokines in Chronic Rhinosinusitis (2010) (88)
Glucocorticoids Enhance or Spare Innate Immunity: Effects in Airway Epithelium Are Mediated by CCAAT/Enhancer Binding Proteins1 (2007) (88)
Immunolocalization of CD34 in nasal polyposis. Effect of topical corticosteroids. (1999) (88)
Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis (2012) (88)
The mechanisms of antiinflammatory steroid action in allergic diseases. (1985) (87)
Interleukin 1 production by human lung tissue. II. Inhibition by anti-inflammatory steroids. (1987) (85)
Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease (2017) (84)
Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. (2001) (84)
Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not non‐eosinophilic, chronic rhinosinusitis with nasal polyps (2014) (84)
Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophilia. (2015) (83)
The epithelium as a target of glucocorticoid action in the treatment of asthma. (1996) (83)
Differences in the behavior of cytoplasmic granules and lipid bodies during human lung mast cell degranulation (1984) (83)
Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps. (2011) (82)
Migration of Eosinophils Across Endothelial Cell Monolayers: Interactions Among IL-5, Endothelial-Activating Cytokines, and C-C Chemokines1 (2000) (82)
Preliminary identification and role of phosphodiesterase isozymes in human basophils. (1992) (82)
Immunoglobulin E-mediated degranulation of isolated human lung mast cells. (1985) (82)
Epithelial Genes in Chronic Rhinosinusitis with and without Nasal Polyps (2008) (80)
Innate immunity of the sinonasal cavity: expression of messenger RNA for complement cascade components and toll-like receptors. (2004) (80)
Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation. I. Evidence for activation of alveolar macrophages, but not peripheral blood monocytes, in subjects with allergic rhinitis and asthma. (1997) (79)
Pharmacokinetics of fentanyl as determined by radioimmunoassay (1978) (78)
Gene polymorphisms, breast-feeding, and development of food sensitization in early childhood. (2011) (78)
Asthmatics with exacerbation during acute respiratory illness exhibit unique transcriptional signatures within the nasal mucosa (2014) (77)
Adult chronic rhinosinusitis (2020) (76)
Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity. (2014) (76)
Gene–vitamin D interactions on food sensitization: a prospective birth cohort study (2011) (76)
An african-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity. (2008) (75)
12/15-Lipoxygenase deficiency protects mice from allergic airways inflammation and increases secretory IgA levels. (2008) (75)
Superantigens and Chronic Rhinosinusitis: Skewing of T-Cell Receptor Vβ-Distributions in Polyp-Derived CD4+ and CD8+ T Cells (2006) (73)
Serum Amyloid A, Properdin, Complement 3, and Toll-Like Receptors are Expressed Locally in Human Sinonasal Tissue (2006) (73)
Interleukin-5 expression in the bone marrow of sensitized Balb/c mice after allergen challenge. (1998) (72)
Differential regulation of human basophil and lung mast cell function by adenosine. (1991) (69)
Adherence of human basophils to cultured umbilical vein endothelial cells. (1988) (69)
Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in an Academic Setting. (2019) (69)
Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps. (2012) (69)
Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. (1989) (67)
Codeine induces human mast cell chemokine and cytokine production: involvement of G‐protein activation (2007) (67)
Glucocorticoid receptor translational isoforms underlie maturational stage-specific glucocorticoid sensitivities of dendritic cells in mice and humans. (2013) (67)
Do cytokines play a role in leukocyte recruitment and activation in the lungs? (1991) (66)
Flow cytometric methods for the analysis of human basophil surface antigens and viability. (1989) (66)
Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes. (2019) (64)
Human mast cells synthesize new granules during recovery from degranulation. In vitro studies with mast cells purified from human lungs. (1988) (64)
Characterization of Specific Antibody Deficiency in Adults with Medically Refractory Chronic Rhinosinusitis (2011) (64)
Variation in dinucleotide (GT) repeat sequence in the first exon of the STAT6 gene is associated with atopic asthma and differentially regulates the promoter activity in vitro (2004) (62)
Modulation of MHC class II expression in human cells by dexamethasone. (1995) (62)
Challenges and disparities in the application of personalized genomic medicine to populations with African ancestry (2016) (62)
Functional desensitization of beta agonist responses in human lung mast cells. (1995) (60)
Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin. (2020) (60)
Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. II. Interaction with other stimuli. (1982) (60)
Potential regulation of inflammation in the lung by local metabolism of hydrocortisone. (1991) (59)
Human mast cells use conservation and condensation mechanisms during recovery from degranulation. In vitro studies with mast cells purified from human lungs. (1986) (58)
Inhibition of T cell-mediated cytotoxicity by anti-inflammatory steroids. (1984) (57)
Interferon-γ Inhibits STAT6 Signal Transduction and Gene Expression in Human Airway Epithelial Cells (2004) (57)
Age-related differences in the pathogenesis of chronic rhinosinusitis. (2011) (57)
Morphologic mast cell cycles. (1987) (56)
Generation of leukotriene B4 by human lung fragments and purified human lung mast cells. (1988) (56)
The effects of inhaled budesonide on circulating eosinophil progenitors and their expression of cytokines after allergen challenge in subjects with atopic asthma. (2000) (56)
An in vitro comparison of commonly used topical glucocorticoid preparations. (1999) (56)
BCL‐2 protects human and mouse Th17 cells from glucocorticoid‐induced apoptosis (2016) (56)
Differential expression of interleukin‐32 in chronic rhinosinusitis with and without nasal polyps (2012) (55)
Human endothelial cells prolong eosinophil survival. Regulation by cytokines and glucocorticoids. (1989) (55)
Association study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations (2019) (55)
Gene encoding Duffy antigen/receptor for chemokines is associated with asthma and IgE in three populations. (2008) (54)
Differential Enzymatic Activity of Common Haplotypic Versions of the Human Acidic Mammalian Chitinase Protein* (2009) (54)
Expression of interleukin-16 by human epithelial cells. Inhibition by dexamethasone. (1999) (54)
Proton pump inhibitors decrease eotaxin‐3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K‐ATPase (2017) (54)
Chronic rhinosinusitis: the unrecognized epidemic. (2013) (54)
Dexamethasone and FK506 Inhibit Expression of Distinct Subsets of Chemokines in Human Mast Cells1 (2009) (54)
Substance P primes lipoteichoic acid‐ and Pam3CysSerLys4‐mediated activation of human mast cells by up‐regulating Toll‐like receptor 2 (2010) (54)
Human lung macrophages enhance and inhibit lymphocyte proliferation. (1984) (53)
Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. (1984) (53)
Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes (2013) (52)
Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma. (2014) (52)
Expression of a functional laminin receptor (alpha 6 beta 1, very late activation antigen-6) on human eosinophils (1993) (51)
IgE-dependent regulation of human basophil adherence to vascular endothelium. (1989) (51)
Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody (2021) (50)
Expression of activation markers on alveolar macrophages in allergic asthmatics after endobronchial or whole-lung allergen challenge. (2002) (50)
Comparison of human eosinophil and neutrophil ligands for P-selectin: ligands for P-selectin differ from those for E-selectin. (1995) (50)
Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis. (2015) (49)
Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells. (2015) (48)
Local release of B cell-activating factor of the TNF family after segmental allergen challenge of allergic subjects. (2008) (48)
GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor. (1993) (47)
Protection by dexamethasone of the functional desensitization to β2‐adrenoceptor‐mediated responses in human lung mast cells (1997) (47)
Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: In vivo and in vitro studies. (2008) (47)
The effects of the potent glucocorticoid budesonide on adhesion of eosinophils to human vascular endothelial cells and on endothelial expression of adhesion molecules. (1993) (46)
Store-Operated Ca2+ Release-Activated Ca2+ Channels Regulate PAR2-Activated Ca2+ Signaling and Cytokine Production in Airway Epithelial Cells (2015) (45)
The nasal microbiome in patients with chronic rhinosinusitis: Analyzing the effects of atopy and bacterial functional pathways in 111 patients. (2018) (45)
Double‐stranded RNA activates RANTES gene transcription through co‐operation of nuclear factor‐κB and interferon regulatory factors in human airway epithelial cells (2004) (44)
Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor. (1991) (43)
The pharmacologic modulation of the release of arachidonic acid metabolites from purified human lung mast cells. (1985) (43)
Naturally occurring tolerance acquisition to foods in previously allergic children is characterized by antigen specificity and associated with increased subsets of regulatory T cells (2015) (43)
Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling. (2015) (42)
The Longitudinal Trajectory of Vitamin D Status from Birth to Early Childhood on the Development of Food Sensitization (2013) (42)
Production of granulocyte/macrophage colony-stimulating factor in human airways during allergen-induced late-phase reactions in atopic subjects. (1992) (41)
Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients (2017) (41)
A pilot study of symptom profiles from a polyp vs an eosinophilic‐based classification of chronic rhinosinusitis (2016) (41)
Appearance of granulocyte-macrophage colony-stimulating factor activity at allergen-challenged cutaneous late-phase reaction sites. (1993) (41)
Interactions between the hypothalamic-pituitary-adrenal axis and allergic inflammation. (2000) (40)
The role of adhesion molecules in allergic inflammation and their suitability as targets of antiallergic therapy. (1998) (39)
A plasminogen activator inhibitor-1 inhibitor reduces airway remodeling in a murine model of chronic asthma. (2012) (39)
A retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men (2015) (39)
Discovery, Function, and Therapeutic Targeting of Siglec-8 (2020) (39)
Expression of the costimulatory molecule B7-H2 (inducible costimulator ligand) by human airway epithelial cells. (2003) (39)
Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. (1991) (39)
Does genetic regulation of IgE begin in utero? Evidence from T(H)1/T(H)2 gene polymorphisms and cord blood total IgE. (2010) (37)
Allergens stimulate store-operated calcium entry and cytokine production in airway epithelial cells (2016) (37)
Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics. A National Institute of Allergy and Infectious Diseases Workshop. (2020) (35)
Inhaled glucocorticoids in asthma : mechanisms and clinical actions (1997) (35)
Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice. (2013) (35)
Chronic rhinosinusitis in the setting of other chronic inflammatory diseases. (2011) (35)
A sensitive high throughput ELISA for human eosinophil peroxidase: a specific assay to quantify eosinophil degranulation from patient-derived sources. (2012) (34)
Qualitative differences between dimeric and trimeric stimulation of human basophils. (1983) (34)
Effects of prostaglandin synthesis inhibition on the immune response. (1981) (34)
Chronic airway inflammation provides a unique environment for B cell activation and antibody production (2017) (34)
A Mass Balance Study to Evaluate the Biotransformation and Excretion of [14C]‐Triamcinolone Acetonide following Oral Administration (2000) (33)
A role for anti‐BP180 autoantibodies in chronic rhinosinusitis (2013) (33)
Elevated presence of myeloid dendritic cells in nasal polyps of patients with chronic rhinosinusitis (2015) (33)
The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease (2017) (33)
Asthma onset pattern and patient outcomes in a chronic rhinosinusitis population (2018) (33)
Mediator release from human basophils and mast cells from lung and intestinal mucosa. (1985) (33)
Inhibition of human basophil leukotriene release by antiinflammatory steroids. (1985) (33)
The Clinical Significance of Specific Antibody Deficiency (SAD) Severity in Chronic Rhinosinusitis (CRS). (2014) (33)
IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells. (2017) (32)
RNA Is Closely Associated with Human Mast Cell Secretory Granules, Suggesting a Role(s) for Granules in Synthetic Processes (2000) (32)
Chronic Rhinosinusitis and the Coagulation System (2015) (31)
Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis. (2016) (31)
Identifying tagging SNPs for African specific genetic variation from the African Diaspora Genome (2017) (31)
Association of elevated plasminogen activator inhibitor 1 levels with diminished lung function in patients with asthma. (2011) (31)
Application of a flow cytometric method using autofluorescence and a tandem fluorescent dye to analyze human alveolar macrophage surface markers. (1994) (31)
Simultaneous quantitation of endogenous levels of cortisone and cortisol in human nasal and bronchoalveolar lavage fluids and plasma via gas chromatography-negative ion chemical ionization mass spectrometry. (1994) (31)
Diamine oxidase-gold labels histamine in human mast-cell granules: a new enzyme-affinity ultrastructural method. (1993) (31)
Differential regulation of eotaxin expression by IFN-γ in airway epithelial cells ☆ ☆☆ (2003) (30)
Clinical characteristics of adults with chronic rhinosinusitis and specific antibody deficiency. (2015) (30)
Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps. (2020) (29)
Inhaled Steroids in Asthma: Optimizing Effects in the Airways (2001) (29)
Epithelial activators of type 2 inflammation: Elevation of thymic stromal lymphopoietin, but not IL‐25 or IL‐33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois (2018) (29)
Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"? (2005) (29)
Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. (1986) (29)
Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression (2016) (29)
Role of Aspergillus fumigatus in Triggering Protease-Activated Receptor-2 in Airway Epithelial Cells and Skewing the Cells toward a T-helper 2 Bias. (2015) (28)
Five‐year risk of incident disease following a diagnosis of chronic rhinosinusitis (2015) (28)
Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cells. (2004) (28)
Substance P downregulates expression of the high affinity IgE receptor (FcεRI) by human mast cells (2010) (28)
Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis (2017) (27)
Risk of obstructive sleep apnea in African American patients with chronic rhinosinusitis. (2017) (27)
Prevalence, severity, and risk factors for acute exacerbations of nasal and sinus symptoms by chronic rhinosinusitis status (2018) (27)
Functional regulation of beta 1 integrins on human eosinophils by divalent cations and cytokines. (1996) (27)
Purified human basophils and mast cells: current concepts of mediator release. (1983) (26)
Regulation of the action of hydrocortisone in airway epithelial cells by 11beta-hydroxysteroid dehydrogenase. (1999) (26)
Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin‐exacerbated respiratory disease (2017) (26)
Biology of nasal polyposis. (2014) (25)
Differential Regulation of Chemokine Expression by Th1 and Th2 Cytokines and Mechanisms of Eotaxin/CCL-11 Expression in Human Airway Smooth Muscle Cells (2007) (24)
Retinoic acid inhibits interleukin-4-induced eotaxin production in a human bronchial epithelial cell line. (2004) (24)
Inhibition of inflammatory cell recruitment by glucocorticoids: Cytokines as primary targets (1995) (24)
Innate and acquired immunity and epithelial cell function in chronic rhinosinusitis. (2007) (24)
Human mast cells and basophils-structure, function, pharmacology, and biochemistry (1983) (24)
Interleukin 1 production by human lung tissue. I. Identification and characterization. (1987) (24)
Function and expression of adhesion molecules on human basophils. (1994) (24)
Regional differences in the expression of innate host defense molecules in sinonasal mucosa. (2013) (24)
Endotypes of Chronic Rhinosinusitis; relationships to disease phenotypes, pathogenesis, clinical findings and treatment approaches. (2021) (23)
Activation of the 15-Lipoxygenase Pathway in Aspirin Exacerbated Respiratory Disease. (2020) (23)
Short‐chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR41&43 (2018) (23)
Dexamethasone inhibits the antigen-induced contractile activity and release of inflammatory mediators in isolated guinea pig lung tissue. (1987) (23)
Cross-talk between human mast cells and bronchial epithelial cells in plasminogen activator inhibitor-1 production via transforming growth factor-β1. (2015) (22)
Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in humans (2017) (22)
African American Patients with Chronic Rhinosinusitis Have a Distinct Phenotype of Polyposis Associated with Increased Asthma Hospitalization. (2016) (22)
Basic Research on Virus-Induced Asthma Exacerbation: Inhibition of Inflammatory Chemokine Expression by Fluticasone Propionate (2013) (22)
Pharmacologic and biochemical studies of human lung mast cells (MC) (1982) (21)
Radiologic sinus inflammation and symptoms of chronic rhinosinusitis in a population‐based sample (2019) (21)
Human Lung Mast Cell and Alveolar Macrophage Cytoplasmic Lipid Bodies Contain Arachidonic Acid and Prostaglandin Endoperoxide Synthase (Cyclooxygenase), the Substrate and Enzyme Necessary for Prostaglandin Production. (1992) (21)
Cooperative Activation of CCL5 Expression by TLR3 and Tumor Necrosis Factor-α or Interferon-γ through Nuclear Factor-ĸB or STAT-1 in Airway Epithelial Cells (2010) (21)
Evidence for altered levels of IgD in the nasal airway mucosa of patients with chronic rhinosinusitis (2017) (21)
Prevalence and characteristics of peanut allergy in US adults. (2021) (20)
Pathogenic and protective roles of B cells and antibodies in patients with chronic rhinosinusitis (2018) (20)
Inhibition by adenosine of histamine and leukotriene release from human basophils. (1989) (20)
Sleep disruption in chronic rhinosinusitis (2017) (19)
Mechanisms and pathogenesis of chronic rhinosinusitis. (2022) (18)
The effects of anti-inflammatory steroids on mast cells (1993) (18)
The pathophysiology of human mast cells. In vitro and in vivo function. (1987) (17)
Suppression of epithelial signal transducer and activator of transcription 1 activation by extracts of Aspergillus fumigatus. (2014) (17)
Genome-wide association study of maternal genetic effects and parent-of-origin effects on food allergy (2018) (17)
Double-stranded RNA activates RANTES gene transcription through co-operation of nuclear factor-kappaB and interferon regulatory factors in human airway epithelial cells. (2004) (17)
Prevalence of allergic rhinitis and asthma in patients with chronic rhinosinusitis and gastroesophageal reflux disease. (2016) (17)
A prospective analysis evaluating tissue biopsy location and its clinical relevance in chronic rhinosinusitis with nasal polyps (2017) (17)
Prevalence and characterization of chronic rhinosinusitis in patients with non‒cystic fibrosis bronchiectasis at a tertiary care center in the United States (2019) (16)
Molecular Mechanisms of Repression of Eotaxin Expression with Fluticasone Propionate in Airway Epithelial Cells (2004) (16)
The pharmacologic control of mediator release from human basophils and mast cells. (1986) (16)
A Recently Established Murine Model of Nasal Polyps Demonstrates Activation of B Cells, as Occurs in Human Nasal Polyps. (2016) (16)
Assessment of signal transducer and activator of transcription 6 as a target of glucocorticoid action in human airway epithelial cells (2004) (16)
The quest for autoreactive antibodies in nasal polyps. (2016) (15)
Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps (2019) (15)
Uptake, Retention, and Biotransformation of Corticosteroids in the Lung and Airways (2001) (15)
Transforming growth factor‐β stimulates the expression of eotaxin/CC chemokine ligand 11 and its promoter activity through binding site for nuclear factor‐κB in airway smooth muscle cells (2010) (15)
The anti-inflammatory profile of inhaled corticosteroids: biopsy studies in asthmatic patients. (2000) (15)
Diamine oxidase‐gold ultrastructural localization of histamine in isolated human lung mast cells stimulated to undergo anaphylactic degranulation and recovery in vitro (1996) (15)
Increased expression of L‐plastin in nasal polyp of patients with nonsteroidal anti‐inflammatory drug‐exacerbated respiratory disease (2018) (14)
Changes in blood leukocyte cytokine expression following repeated nasal allergen provocation: Evidence for systemic manifestations (2002) (14)
Evaluating metrics of responsiveness using patient‐reported outcome measures in chronic rhinosinusitis (2017) (14)
Expression of a functional laminin receptor (alpha 6 beta 1, very late activation antigen-6) on human eosinophils. (1993) (13)
In vitro resistance to dexamethasone of basophils from patients receiving long-term steroid therapy. (1985) (13)
Differential regulation of eotaxin expression by IFN-gamma in airway epithelial cells. (2003) (13)
Association of nasal microbiome and asthma control in patients with chronic rhinosinusitis (2018) (13)
Design and Development of a Soft Corticosteroid, Loteprednol Etabonate (2001) (12)
Detection and quantitation of fatty acid acyl conjugates of triamcinolone acetonide via gas chromatography-electron-capture negative-ion mass spectrometry. (2003) (12)
Systemic Disposition and Effects of Inhaled Corticosteroids (2001) (12)
Corticosteroid treatment in bronchial asthma: for better or for worse? (2003) (12)
Regulatory T-cell populations in children are affected by age and food allergy diagnosis. (2017) (12)
Ultrastructural Autoradiographic Analysis of RNA in Isolated Human Lung Mast Cells during Secretion and Recovery from Secretion (2000) (11)
Role of interleukin-32 in chronic rhinosinusitis (2013) (11)
Measurement of low picomolar levels of triamcinolone acetonide in human bronchoalveolar lavage fluid by gas chromatography-electron-capture negative-ion mass spectrometry. (2001) (11)
Elevation of activated neutrophils in chronic rhinosinusitis with nasal polyps (2021) (11)
Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation (2013) (11)
Longitudinal Evaluation of Chronic Rhinosinusitis Symptoms in a Population-Based Sample. (2017) (11)
Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils. (1992) (11)
Potential Involvement of the Epidermal Growth Factor Receptor Ligand Epiregulin and Matrix Metalloproteinase‐1 in Pathogenesis of Chronic Rhinosinusitis (2017) (10)
The role of prostaglandin D2 in IgE-mediated reactions in man. (1982) (10)
Evaluating the Stability of RNA-Seq Transcriptome Profiles and Drug-Induced Immune-Related Expression Changes in Whole Blood (2015) (10)
Identification of novel inducible genes in airway epithelium. (1997) (10)
Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps. (2014) (10)
Involvement of Toll-like receptor 2 and epidermal growth factor receptor signaling in epithelial expression of airway remodeling factors. (2015) (10)
Is leukotriene B4 an important mediator in human IgE-mediated allergic reactions? (1987) (10)
Clinical Factors Associated with Acute Exacerbations of Chronic Rhinosinusitis. (2017) (10)
Longitudinal evaluation of clustering of chronic sinonasal and related symptoms using exploratory factor analysis (2018) (10)
Lipoxygenase products of arachidonic acid: role in modulation of IgE-induced histamine release. (1982) (10)
Introduction: Systemic Aspects of Allergic Disease (2000) (9)
Common fibrin deposition and tissue plasminogen activator downregulation in nasal polyps with distinct inflammatory endotypes. (2020) (9)
Pharmacology of Glucocorticoids in Allergic Disease (2009) (9)
Genetic variation in B cell-activating factor of the TNF family (BAFF) and asthma exacerbations among African American subjects. (2012) (9)
19 Interaction between hyperosmolar and IgE induced histamine release from basophils and mast cells (1983) (9)
Plasminogen activator inhibitor-1 in sputum and nasal lavage fluids increases in asthmatic patients during common colds (2013) (9)
Prospects for Developing Inhaled Steroids with Extrahepatic Metabolism “Soft Steroids” (2001) (8)
Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa (2021) (8)
Increased thrombin activatable fibrinolysis inhibitor (TAFI) in chronic rhinosinusitis with nasal polyps. (2019) (8)
Aerosol Delivery Devices and Airways/Lung Deposition (2001) (8)
Drug Development of Inhaled Steroids A Pharmacologist’s View Based on Experiences from the Budesonide Project (2001) (8)
Studies with purified human basophils and mast cells. (1983) (8)
Antiinflammatory steroids inhibit granulocyte/macrophage colony-stimulating factor production by human lung tissue (1994) (8)
New aspects of glucocorticoid therapy in immunological disorders: Focus on deflazacort: Discussion (1993) (8)
Analysis of mast cell activation using diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. (1995) (8)
443 The expression of lymphocyte chemoattractant factor (LCF) in human bronchial epithelial cells (1996) (8)
How do steroids work? (1996) (7)
Innate Immune Responses and Chronic Obstructive Pulmonary Disease (2012) (7)
Development and Preliminary Validation of a New Patient Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO). (2020) (7)
Studies of the Role of Basophils in Aspirin Exacerbated Respiratory Disease Pathogenesis. (2021) (7)
Differential Regulation of ATP- and UTP-Evoked Prostaglandin E2 and IL-6 Production from Human Airway Epithelial Cells (2021) (7)
Inflammation: Basic principles and clinical correlates edited by John Gallin, Ira Goldstein and Ralph Snyderman, Raven Press, 1987. $219.00 (xvii + 995 pages) ISBN 0 88167 344 7. (1988) (7)
Prevalence of Bronchiectasis in Patients with Chronic Rhinosinusitis in a Tertiary Care Center. (2021) (7)
Detection of the chemokine receptor CCR3 on endothelial cells. (1998) (7)
Multi-omics colocalization with genome-wide association studies reveals a context-specific genetic mechanism at a childhood onset asthma risk locus (2021) (6)
Mediator Release: Studies with Purified Human Basophils and Mast Cells (1983) (6)
Epithelial responses in airway inflammation and immunity (2004) (6)
In Vitro and In Vivo Model Systems for the Study of Allergic and Inflammatory Disorders in Man : Implications for the Pathogenesis of Asthma (1985) (6)
531 The effect of cytokines on human basophils (1988) (6)
Expression of the Chemokine Rantes In Human Epithelial-cells (1994) (6)
Stimulus-Selective Regulation of Human Mast Cell Gene Expression, Degranulation and Leukotriene Production by Fluticasone and Salmeterol (2014) (6)
IgE-mediated release of inflammatory mediators from human basophils and mast cells in vitro and in vivo (1984) (6)
Mast cell-derived plasminogen activator inhibitor type 1 promotes airway inflammation and remodeling in a murine model of asthma. (2018) (6)
Responsiveness and Convergent Validity of a New Patient Reported outcome measure for Chronic Rhinosinusitis (CRS-PRO). (2020) (6)
Granulocyte colony-stimulating factor blockade enables dexamethasone to inhibit lipopolysaccharide-induced murine lung neutrophils (2017) (5)
Pharmacokinetics of fentanyl in man (1976) (5)
TNF Induces the Production of Type 2 Cytokines in Human Group 2 Innate Lymphoid Cells: 3 (2019) (5)
Wy-48,252 (1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy)phenyl]membrane sulfonamide), an orally active leukotriene antagonist: effects on arachidonic acid metabolism in various inflammatory cells. (1988) (5)
Integrin β6 microparticles in nasal lavage fluids; potential new biomarkers for basal cell activation in chronic rhinosinusitis (2020) (5)
654 GM-CSF enhances PAF- and FMLP-induced eosinophil expression of adherence molecules (CD11b) and increases FMLP-induced adherence to endothelial cells (1991) (5)
Multi-omics colocalization with genome-wide association studies reveals a context-specific genetic mechanism at a childhood onset asthma risk locus (2019) (5)
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis. (2021) (5)
Identification of whole blood mRNA and microRNA biomarkers of tissue damage and immune function resulting from amphetamine exposure or heat stroke in adult male rats (2019) (5)
RI-Mediated Mast Cell Activation e of Fc Tetraspanin CD151 Is a Negative Regulator (2015) (4)
133 Dexamethasone (DEX) selectively inhibits IL-3 priming of basophil, C5a responses (1991) (4)
Selective effects of glucocorticoids (GC) on epithelial responses (2005) (4)
Differential regulation of epithelial-derived C-C chemokines by cytokines and budesonide. (1998) (4)
Airway epithelial cell activation and toll-like receptors (TLR) (2003) (4)
Regulation of lung inflammation by local glucocorticoid metabolism: an hypothesis. (1992) (4)
Injection of Human-subjects With Rantes Causes Dermal Infiltration of Eosinophils (eos) and Mononuclear-cells (mnc) (1995) (4)
Evidence For Immunoglobulin D In Patients With Chronic Rhinosinusitis (2014) (4)
Elevated Serum Leptin Levels in Patients With Eosinophilic Chronic Rhinosinusitis (2022) (4)
Oncostatin M Is Elevated In Chronic Rhinosinusitis and Decreases Barrier Function In Human Airway Epithelium (2014) (4)
271 Allergen-induced late-phase reaction (LPR) sites contain IL-3 and GM-CSF activity (1991) (4)
Complement Activation in Nasal Tissue of Patients with Chronic Rhinosinusitis (2015) (4)
Targetable pathogenic mechanisms in nasal polyposis (2021) (4)
Out of the orphanage and into the clinic--therapeutic targeting of GATA3. (2015) (4)
Post-transcriptional regulation of eotaxin by glucocorticoids (GC) and by interleukin (IL)-4 (2002) (4)
IgE-mediated leukotriene release in vitro and in vivo. (1984) (3)
Epithelial STAT3 activation is associated with expression of the antimicrobial peptide S100A7 (89.14) (2010) (3)
Mast cells and mast cell mediators in models of airway disease. (1985) (3)
Reduced Expression of Antimicrobial Palate, Lung and Nasal Epithelial Clone (PLUNC) protein in Polyps from Patients with Chronic Rhinosinusitis is Due to Decreased Number of Glands (2011) (3)
657 Endothelial-leukocyte adhesion molecule-1 (ELAM-1) expression following cutaneous allergen challenge (1991) (3)
Cross-Talk between Human Mast Cells and Bronchial Epithelial Cells in Plasminogen Activator Inhibitor-1 Production via Transforming Growth Factor- b 1 (2014) (3)
Unified Airway Theory: Association of Bronchiectasis and Chronic Rhinosinusitis (2016) (3)
Epithelial-Cell-Derived Extracellular Vesicles in Pathophysiology of Epithelial Injury and Repair in Chronic Rhinosinusitis: Connecting Immunology in Research Lab to Biomarkers in Clinics (2021) (3)
Prognostic Factors for Polyp Recurrence in Chronic Rhinosinusitis with Nasal Polyps. (2022) (3)
Sex-Specific Differences In Disease Severity In Patients With Chronic Rhinosinusitis With Nasal Polyps (2014) (3)
Relationship of Dose- and Time-Dependent Corticosteroid Responses to Receptor Turnover (2001) (3)
Elevated Presence of Dendritic Cell Subsets in Chronic Rhinosinusitis (2013) (3)
The Differential Relationship Between Regulatory T-Cells and Age in Children with Food Allergy (2015) (3)
Analysis of the TLR2 Signaling Pathway in Nasal Epithelial Cells from Patients with Chronic Rhinosinusitis (CRS) (2007) (3)
R060: Toll-like Receptors Are Expressed in Sinonasal Mucosa (2003) (3)
Heterogenous Inflammation in Chronic Rhinosinusitis without Nasal Polyps (2016) (3)
Molecular diagnostics and lack of clinical allergy in helminth-endemic areas in Indonesia (2017) (3)
A new approach to categorization of radiologic inflammation in chronic rhinosinusitis (2020) (3)
Meta-Analysis Of Gene Expression Microarrays Reveals Novel Biomarkers Consistent With Altered Functionality Of Mucosal Barrier In Patients With Chronic Rhinosinusitis (2014) (3)
Characterization of CCR3 expression on human airway epithelial cells. (1999) (3)
Anti-dsDNA specific antibody secreting cells are increased in both frequency and abundance in Chronic Rhinosinusitis with Nasal Polyps (2020) (3)
Workplace Indirect Cost Impacts of Nasal and Sinus Symptoms and Related Conditions. (2019) (3)
Dispersed Human Lung Mast Cells (2015) (2)
Investigation of Basophils in Aspirin Exacerbated Respiratory Disease Pathogenesis (2019) (2)
Studies on activation and regulation of the coagulation cascade in chronic rhinosinusitis with nasal polyps. (2022) (2)
Synopsis of discussions in session 3: Drug pathways and their interactions in COPD therapy (2005) (2)
Role of TNFSF11 and Group 2 Innate Lymphoid Cells in Type 2 Inflammation in Chronic Rhinosinusitis with Nasal Polyps (2018) (2)
Effects of glucocorticoids on mediator release from human basophils and mast cells (1982) (2)
Induction of tolerance to a soluble antigen following irradiation and bone marrow reconstitution. (1982) (2)
487 A novel C-C chemokine, CKβ10 is expressed in airway epithelial cells and is a potent eosinophil chemoattractant (1996) (2)
Chemokines Endothelial-Activating Cytokines , and C-C Cell Monolayers : Interactions Among IL-5 , Migration of Eosinophils Across Endothelial (2000) (2)
Reduced Expression of Antimicrobial PLUNC Proteins in Nasal Polyp Tissue (2010) (2)
Elevated expression of CC Chemokine ligand 23 in eosinophilic chronic rhinosinusitis with nasal polyps (2011) (2)
969 Cutaneous injection of RANTES causes eosinophil (EOS) recruitment: Comparison of nonallergic (NA) and allergic (A) human subjects (1996) (2)
770 Surface expression of CCR3 and CD49d on eosinophil is not increased in allergic asthma and allergic rhinitis (2000) (2)
Omeprazole Has Anti-Inflammatory Effects on Type 2 Cytokine-Stimulated Human Airway Epithelial Cells (2015) (2)
Adenosine receptor A2a inhibits complement-mediated activation of human mast cells by activating G{alpha}s-proteins (2009) (2)
Elevated Expression of mRNA for CCL2, CCL19, CCR7 and CXCR3 in Chronic Rhinosinusitis with Nasal Polyposis (2012) (2)
Evaluation and Comparison of Inhaled Steroids (2001) (2)
The Impact and Nature of Inflammation in the Olfactory Cleft On Olfaction in Patients with Chronic Rhinosinusitis (2013) (2)
Aspergillus Fumigatus May Promote Th2 Activation By Suppression Of Interferon Signaling (2014) (2)
Patient Adherence to Inhaled Corticosteroid Therapy (2001) (2)
Systemic imbalance in hormone levels associates with epithelial barrier dysfunction in allergic disease (2017) (2)
Regulation and function of newly-recognized IL-1 family cytokines in human bronchial epithelial cells (2009) (2)
Radioimmunoassay of fentanyl: pharmacokinetics in man. (1976) (2)
Strong and consistent associations of precedent chronic rhinosinusitis with risk of non-cystic fibrosis bronchiectasis. (2022) (2)
Effects of Reslizumab on Nasal Polyp Inflammation in Aspirin Exacerbated Respiratory Disease (2018) (2)
Evidence for Elevated IL-6 and its Signaling Components in Chronic Rhinosinusitis with Nasal Polyps (2007) (2)
Eosinophils in Human Disease (2012) (2)
THE ROLE OF LIPOXYGENASE PRODUCTS OF ARACHIDONIC ACID IN INFLAMMATORY EVENTS MEDIATED BY HUMAN BASOPHILS AND MAST CELLS (1983) (2)
Studies on the Mechanisms by Which Glucocorticoids Inhibit Tissue Eosinophilia in Allergic Reactions. (1992) (2)
Substance P Modulates Toll-like Receptor-Mediated Activation Of Human Mast Cells (2009) (2)
STAT3 and NF-kB Regulate S100A7 Expression in Human Bronchial Epithelial Cells (2012) (2)
Clinical Characteristics of Aspirin Exacerbated Respiratory Disease in a Tertiary Care Patient Cohort (2016) (2)
Reduced Serum Levels of Innate Immune Molecules in Subjects with Frequent Asthma Exacerbations (2006) (1)
B cell-activating Factor of the TNF Family (BAFF) and a Proliferation-inducing Ligand (APRIL) Expression in Chronic Rhinosinusitis (2008) (1)
The effect of endotoxin on immediate hypersensitivity as assessed by puncture skin testing. (1987) (1)
Nasal secretion tissue plasminogen activator, a novel effective predictor of nasal polyp recurrence. (2022) (1)
Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial (2022) (1)
Suppression of Allergic Asthma by Loss of Function of Miz1-Mediated Th1 Skewing. (2022) (1)
Investigation of Molecular Characteristics of Aspirin Exacerbated Respiratory Disease (2015) (1)
IL-32 Expression in Chronic Rhinosinusitis (2010) (1)
Childhood Asthma and Growth (2001) (1)
Newly Recognized Glucocorticoid Targets (2001) (1)
Specificity of mouse leukocyte binding to insolubilized histamine. (1979) (1)
Interferon-Inhibits STAT 6 Signal Transduction and Gene Expression in Human Airway Epithelial Cells (2004) (1)
Markers of Systemic Actions of Corticosteroids (2001) (1)
Levels of the Cytokines IL-5, IL-13 and Rantes in Nasal Lavage Fluids Parallel the Cytokine Content of Nasal Polyps in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) (2013) (1)
Airway epithelial cells express multiple members of the B7 family (2003) (1)
ProteinsMediated by CCAAT/Enhancer Binding Immunity: Effects in Airway Epithelium Are Glucocorticoids Enhance or Spare Innate (2007) (1)
367 The cell surface antigens CD44 and CD69 are activation markers for human eosinophils (EOS) (1996) (1)
Inhibition of the attachment of PMNs to vascular endothelial cells by dexamethasone (1985) (1)
Analysis of the Th17 Pathway in Chronic Rhinosinusitis (2009) (1)
Association of common filaggrin null mutations with atopy but not chronic rhinosinusitis. (2015) (1)
Thymic stromal lymphopoietin activity is increased in nasal polyps of chronic rhinosinusitis (2013) (1)
409 Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in human inflammatory cells (1991) (1)
Inhibition of the non-gastric H+/K+-ATPase (ATP12A) by ilaprazole and vonoprazan decreased IL-13-stimulated eotaxin-3 expression in airway epithelial cells. (2020) (1)
Epithelial Cell Innate Responses to Rhinovirus Infection (2009) (1)
A Novel Role for 15-Lipoxygenase Metabolites in Aspirin Exacerbated Respiratory Disease (2020) (1)
Modulation in vitro of hydrogen peroxide toxicity to human tracheal epithelial cells by neutrophils (1988) (1)
humans stage-specific glucocorticoid sensitivities of dendritic cells in mice and Glucocorticoid receptor translational isoforms underlie maturational (2013) (1)
2. MECHANISMS OF STEROID ACTION (1996) (1)
Local autoantibodies in Chronic Rhinosinusitis (CRS) with Nasal Polyps. (48.8) (2010) (1)
Enhanced Expression of Innate Immune Genes in Chronic Rhinosinusitis (2006) (1)
Chronic rhinosinusitis linked to high microbiome dissimilarity among different patients and within individuals over time. (2020) (1)
219 Relationships between symptoms, mediators, and cells in the late-phase reaction to nasal antigen challenge (2000) (1)
Regulatory roles of histamine in the immune system. (1978) (1)
Antibiotic Use In Patients With Chronic Rhinosinusitis, With and Without Bronchiectasis, After Functional Endoscopic Sinus Surgery (2018) (1)
Post-Translational Modification By Serine Proteases Controls The CCL23 Activity In Nasal Polyps Of Chronic Rhinosinusitis (2014) (1)
Docetaxel in adjuvant therapy of breast cancer : results of the TAXIT 216 multicenter phase III trial ” (2008) (1)
CURRENT, NEW, AND EMERGING ASTHMA THERAPIES (2008) (1)
Lipoxygenase Products of Arachidonic Acid: their Role in Inflammatory Events Mediated by Human Basophils and Mast Cells (1983) (1)
Evidence for intranasal anti-nuclear autoantibodies in Chronic Rhinosinusitis with Nasal Polyps. (2012) (1)
Differential effects of fluticasone propionate (FP) on gene expression in airway epithelial cells (2004) (1)
Selective Activation of the 15-Lipoxgyenase Pathway in Aspirin Exacerbated Respiratory Disease (2020) (1)
Group 2 Innate Lymphoid Cells Directly Induce B Cell Activation in Humans (2016) (1)
Evidence for circadian rhythm disruption in chronic rhinosinusitis (2017) (1)
Pathways to Chronic Rhinosinusitis: Molecular to Microbial and Back (2018) (0)
Use of the LAD-2 Mast Cell Line to Assess Mast Cell Degranulation Induced by Sera From Chronic Idiopathic Urticaria Patients (2006) (0)
Mechanisms of Allergic Disease: A Celebration of 25 Years of Collaboration with Japan (2014) (0)
Genome-wide association study of asthma in individuals of African ancestry reveals novel asthma susceptibility loci (2017) (0)
R154: Chitinase Expression in Chronic Rhinosinusitis (2007) (0)
Elevation of Plasminogen Activator Inhibitor-1 Levels in Sputum and Nasal Lavage Fluids of Asthmatics with Common Colds (2013) (0)
Co-Signalling Molecules (B7 homologs) are Expressed by Human Keratinocytes (2006) (0)
Oncostatin M promotes epithelial barrier dysfunction and is elevated in eosinophilic mucosal disease (HYP7P.255) (2015) (0)
Airway epithelial cells enhances tissue plasminogen activator by short chain fatty acids via G protein coupled receptor 41 and 43 (2018) (0)
Selective gene regulation by glucocorticoid receptor translational isoforms in T cells. (46.10) (2011) (0)
Respiratory Virus Detection in Nasal Lavage Fluid of Chronic Rhinosinusitis Patients During Acute Exacerbations (2019) (0)
Selective regulation of glucocorticoid receptor translational isoforms in T cells and B cells (85.7) (2010) (0)
Transcriptomic signatures convergent across multiple studies of upper and lower airway allergic disease support the unified airway hypothesis (HUM7P.321) (2014) (0)
The Pathophysiology of Human Mast Cells (2015) (0)
Selective inhibition of cyclooxygenase product release from human lung fragments by dexamethasone (1984) (0)
Subject Index Vol. 143, Suppl. 1, 2007 (2007) (0)
Association of L‐plastin Expression With Recalcitrant Nasal Polyps In The Patients With Aspirin‐Exacerbated Respiratory Disease: 876 (2019) (0)
Contents, vol. 50, Supplement 2, 1986 (1986) (0)
Enhanced Production of Plasminogen Activator Inhibitor-1 from Bronchial Epithelial Cells by Activated Human Mast Cells (2009) (0)
Mast Cells with a Unique Phenotype Are Highly Elevated in Chronic Rhinosinusitis with Nasal Polyps (2012) (0)
Transcription Factors AP-1 and NF-kB as Targets for Development of Anti-in.ammatory Drugs (2001) (0)
3 THE ROLES OF CYTOKINES AND CHEMOKINES IN ALLERGIC INFLAMMATION (1996) (0)
Synopsis of Discussions in Session 3 (2012) (0)
439 Phenotyping and cytokine regulation of the human bronchial epithelial cell line BEAS-2B (1996) (0)
A biomarker for obstructive sleep apnea in chronic rhinosinusitis: 265 (2019) (0)
Eosinophil–Endothelial Interactions and Transendothelial Migration (2020) (0)
Regulation of signal transducer and activator of transcription 6, (STAT6), by interferon-gamma (IFN-gamma) (2003) (0)
Sleep Disruption in Chronic Rhinosinusitis: Risk Factors Predictive of Worse Sleep Quality (2017) (0)
Genetic Determinants of Food Sensitization in Early Childhood: A Prospective Birth Cohort Study (2010) (0)
Elevated Presence of Basophils in Chronic Rhinosinusitis with Nasal Polyposis (2013) (0)
Regulation of Tissue Plasminogen Activator Expression in Human Epithelial Cells (2015) (0)
Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in chronic rhinosinusitis (2016) (0)
Induction of Airway BAFF during Upper Respiratory Infections in Patients with Asthma (2016) (0)
Human Airway Epithelial Cells Produce Thymic Stromal Lymphopoietin (TSLP) after Stimulation with Th2 Cytokines and TLR3 Ligand (2007) (0)
Activation of Epithelial Cells and Lymphocytes by Staphylococcal Enterotoxin B Induces Profound Expression of Inflammatory Cytokines and Chemokines (2006) (0)
Increased Expression of the Epithelial Anion Transporter Pendrin in Nasal Polyp Tissues of Patients with Chronic Rhinosinusitis (2013) (0)
Retinoic acid promotes fibrinolysis and may regulate polyp formation. (2022) (0)
Dinucleotide (GT) repeat variants in the first exon of the STAT6 gene differentially regulate the promoter activity in vitro (2003) (0)
Subject Index Vol. 134, Suppl. 1, 2004 (2004) (0)
Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps (2019) (0)
Cross-Talk Between Human Mast Cells and Bronchial Epithelial Cells In The Production Of Plasminogen Activator Inhibitor-1 Via TGF-β1 (2014) (0)
Excessive Fibrin Deposition Caused by a Fibrinolytic Disorder Associated with Reduction of Tissue Plaminogen Activator Expression in Nasal Polyps (2013) (0)
1108 Expression of CC-chemokine receptors in the human bronchial epithelial cell line BEAS-2B (2000) (0)
Airway epithelial cells activate Th2 cytokine production in mast cells via IL-1 and thymic stromal lymphopoietin (2012) (0)
The role of chemokines in allergic diseases of the airways (2000) (0)
The Prevalence Of AERD In a Tertiary Care Center (2014) (0)
Detection of Staphylococcus Aureus by Real-Time PCR in Chronic Rhinosinusitis with Nasal Polyps (2006) (0)
in severe mucocutaneous HSV-2 infections: Response to IFN- g therapy (2016) (0)
Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps. (2023) (0)
Contents, Vol. 99, 1992 (1992) (0)
5. CURRENT CONCEPTS ON THE MECHANISM OF ACTION OF CLUCOCORTICOIDS IN ALLERGIC REACTIONS. (1991) (0)
501 Expression of activation markers on alveolar macrophages (AM) in allergic asthmatics after endobronchial (EB) or whole lung (WL) allergen challenge (1996) (0)
Antibody-Secreting Cells Are Elevated in Nasal Polyps of Crswnp Patients and Correlate with Complement Activation (2017) (0)
Rapid publication Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils (2000) (0)
Risk of new onset and prevalent disease in chronic rhinosinusitis: a prospective cohort study. (2023) (0)
Airway Selectivity of Current Inhaled Corticosteroids in Properly Designed Studies (2001) (0)
List of Lectures by Speakers Who Have Not Submitted Their Manuscripts (2013) (0)
Chronic Rhinosinusitis Patients with Gastroesophageal Reflux Disease Have Significantly Higher Prevalence of Atopic Conditions (2016) (0)
CD44 surface expression is increased on human eosinophils activated in vitro and in vivo (1996) (0)
EBI2 expression is associated with B cell inflammation in human sinuses (120.35) (2012) (0)
Human Mast Cells Express Neurokinin and Vasoactive Intestinal Peptide Receptors (2006) (0)
Two decades before the mast. (2010) (0)
IL3 The Role of Epithelium in Innate Immunity and Inflammation in Chronic Rhinosinusitis (2009) (0)
High Plasma Levels of Plasminogen Activator Inhibitor-1 are Associated with Decreased Lung Function in Asthmatic Patients (2010) (0)
Basophil Microparticles in Blood and Nasal Lavage of Chronic Rhinosinusitis and Aspirin Exacerbated Respiratory Disease; New Biomarkers for Basophil Activation (2017) (0)
SL9 Inflammatory and Immune Responses in the Upper Airways and Sinuses of Humans (2009) (0)
Host Defense, Inflammation and Remodeling in the Upper Airway (2014) (0)
Activation of the Innate and Adaptive Immune Systems in Nasal Polyposis (2015) (0)
Iconographies supplémentaires de l'article : Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps (2011) (0)
Aspergillus Fumigatus Extract Suppressed mRNA Expression of the BAFF and IP-10 in Epithelial Cells (2013) (0)
534 IgE-dependent and independent regulation of human basophil adhesiveness (1988) (0)
The role of 11β-hydroxysteroid dehydrogenase in regulating glucocorticoid action (2001) (0)
Elevated Expression of CC Chemokine Ligand 18 in Chronic Rhinosinusitis (2011) (0)
Enhancement of Host Defense Gene Expression by Glucocorticoids (GC) is Mediated by CCAAT-Enhancer Binding Protein (C/EBP) (2006) (0)
Differential Regional Expression Of Innate Immune Antimicrobial Proteins In Sinonasal Mucosa (2012) (0)
Modulation of expression of B7 homologs by human rhinovirus and double-stranded RNA in airway epithelial cells in vitro and in vivo (2004) (0)
A Method For Assessing Regional Determinants Of Eosinophilia In Chronic Rhinosinusitis (2014) (0)
Faculty Opinions recommendation of Pulmonary neuroendocrine cells amplify allergic asthma responses. (2018) (0)
[Comparison of the inhibitory effects of glucocorticoids on the expression of eotaxin in airway epithelial cell line BEAS-2B]. (2004) (0)
The Metabolism of Arachidonic Acid by Purified Human Lung Mast Ceils (1985) (0)
Late Breaking Oral Abstract Session: Basic Science (2018) (0)
Endotyping of chronic rhinosinusitis with nasal polyp based on eosinophil, mast cell and basophil microparticles in nasal lavage fluid (2020) (0)
Post-Translational Modification of CCL23 in Chronic Rhinosinusitis with Nasal Polyps (2013) (0)
Age-related Reduction Of S100A8/A9 In Chronic Rhinosinusitis Is Associated With Increased Production Of Soluble gp130 (2012) (0)
Immunochemical studies on the enkephalins and endorphins. (1979) (0)
IS4-2 Eosinophils, Other Inflammatory Cells, and Molecules in Allergy(Session 4: Animal models and disease,Eosinophils, other Inflammatory Cells and Molecules in Allergy) (2009) (0)
List of Lectures (2010) (0)
Proton Pump Inhibitors (PPIs) May Modulate More Than Just Reflux in Chronic Rhinosinusitis with Nasal Polyps (2016) (0)
Basophil Activation in Aspirin Exacerbated Respiratory Disease (2017) (0)
Mitochondrial Oxidative Stress Is Associated With Age-Related Glandular Remodeling And Nasal Polyp Formation (2018) (0)
Functional Anti-Phospholipid Antibodies are Elevated in Chronic Rhinosinusitis with Nasal Polyp Tissue (2018) (0)
Oncostatin M is produced by neutrophils, and promotes epithelial barrier dysfunction in mucosal airways disease (2016) (0)
lnterleukin-4, lnterleukin-13, Signal Transducer and Activator of Transcription factor 6, and Allergic Asthma (2015) (0)
Glucocorticoids block endotoxin-induced, P-selectinmediated leukocyte-endothelial interactions in the rat (1996) (0)
ILV6 The Role of Epithelium in inflammation and immunity in the airways (2007) (0)
Differential regulation of epithelial eotaxin expression by IFN-gamma and its molecular mechanism (2002) (0)
Assay development for detection and quantitation of fatty acid acyl conjugates of hydrocortisone by gas chromatography-electron capture negative ion mass spectrometry (GC-ECNI-MS) (2002) (0)
IL-10 Prevents the Production of Type 2 Cytokines in Human Group 2 Innate Lymphoid Cells (2017) (0)
Non-Eosinophilic Nasal Polyps In Second-Generation Asian Patients In The U.S. With Chronic Rhinosinusitis; Evidence For Genetic Influence On Eosinophilia (2014) (0)
Neutrophils are a major source of the epithelial barrier disrupting cytokine Oncostatin M in mucosal airways disease. (2016) (0)
The TLR7 Ligand Loxoribine Induces Pentraxin 3 Expression in Peripheral Blood Mononuclear Cells (2006) (0)
Regulation of STAT6 by interferon- (IFN-) γ in human airway epithelial cells (2004) (0)
FUTURE THERAPIES FOR ALLERGIC DISEASES OF THE AIRWAYS (1999) (0)
Reversible Glucocorticoid Esteri.cation (2001) (0)
Elevated Expression of CC Chemokine Ligand 23 in Chronic Rhinosinusitis (2010) (0)
LATE-BREAKING ABSTRACTS PRESENTED AT SCIENTIFIC SESSIONS 2018 AAAAI / WAO JOINT CONGRESS MARCH 2-5 , 2018 (2018) (0)
Inflammation, Immunity and Remodeling in Chronic Rhinosinusitis (2013) (0)
Regulation Of Expression Of Pendrin Protein In CRS With Nasal Polyps and In Airway Epithelial Cells (2014) (0)
Use of intraoperative frontal sinus mometasone‐eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps (2022) (0)
TLR3 Stimulation Induces Production of B Cell-Activating Factor of the TNF Family (BAFF) in Human Airway Epithelial Cells (2006) (0)
Maintenance of Certification clinical management series (2014) (0)
R064: Short-Course Oral Medrol Selectively Reduces Mucosal Eosinophils in Chronic Sinusitis (2003) (0)
MEX3B inhibits collagen production in eosinophilic nasal polyps by downregulating epithelial cell TGFBR3 mRNA stability. (2023) (0)
Subject Index Vol. 152, Suppl. 1, 2010 (2010) (0)
Experimental Therapy of Peanut Allergy with Ara h2-Fcgamma Fusion Protein in Mice (2011) (0)
T Cells and Group 2 Innate Lymphoid Cells 2 (2022) (0)
Airway epithelial cells express toll-like receptor 3 and its ligand stimulates inflammatory cytokines and chemokines through NF-kB and IRF3 (2004) (0)
Age-Related Differences in B-Cell Inflammatory Responses in Nasal Polyps (2017) (0)
Asthmatics with exacerbation during acute respiratory illness exhibit unique transcriptional signatures within the nasal mucosa (2014) (0)
Human lung macrophages (HLM) produce lymphocyte activating factors which are distinct from interleukin-1 (IL-1) (1984) (0)
Regulation and function of newly-recognized IL-1 family cytokines in human bronchial epithelial cells (98.18) (2009) (0)
Decreased Production of Antimicrobial Peptides in Chronic Rhinosinusitis Associated with Age and Elevated Soluble gp130 (2013) (0)
Detection and quantitation of C16 and C18 fatty acid acyl conjugates of triamcinolone acetonide (TAA) in airway epithelial cells using gas chromatography-mass spectrometry (2003) (0)
Oncostatin M Is Elevated in Mucosal Disease and May Mediate Epithelial Barrier Dysfunction in Vivo (2015) (0)
Reciprocal activation of B cells and group 2 innate lymphoid cells (2018) (0)
Characterization of chemokine responses in purified human basophils (2002) (0)
In lasting tribute: Lawrence M. Lichtenstein, May 31, 1934, to August 5, 2022 (2022) (0)
IL-13 acidifies airway surface liquid pH via an omeprazole inhibitable mechanism (2018) (0)
Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in a Tertiary Care Setting (2016) (0)
Session 1. Environmental factors in allergic disorders (2004) (0)
Differences in the Behavior Lipid Bodies during Human of Cytoplasmic Granules and Lung Mast Cell Degranulation (2003) (0)
Age‐related Gene Expression and Histologic Changes in Human Nasal Polyps: 865 (2019) (0)
B cell-activating Factor of the TNF Family (BAFF) Expression in Chronic Rhinosinusitis with Nasal Polyps (2007) (0)
Airway epithelial acute phase responses (2005) (0)
Role of Thymic Stromal Lymphopoietin (TSLP) in Chronic Rhinosinusitis (2012) (0)
Thymic Stromal Lymphopoietin (TSLP) Expression in Chronic Rhinosinusitis (2009) (0)
Clinical Characteristics of Patients with Chronic Rhinosinusitis and Specific Antibody Deficiency (2012) (0)
Airway Signaling and Cytokine Production in 2+ Channels Regulate PAR2-Activated Ca 2+ Release-Activated Ca 2+ Store-Operated Ca (0)
in Human Mast Cells Chemokines Expression of Distinct Subsets of Dexamethasone and FK506 Inhibit (2009) (0)
Inhaled Corticosteroids and the Natural History of Asthma (2001) (0)
Airway Epithelial Cells Directly Promote Th2 Cytokine Production in Mast Cells via Production of IL-1α and TSLP (2011) (0)
A New Method For Cell Isolation Reveals Elevated Numbers of T and B Lymphocytes In Sinonasal Tissue From Patients With Chronic Rhinosinusitis (2011) (0)
Evidence for Expansion of Sinonasal B-Lineage Cells in Chronic Rhinosinusitis (2013) (0)
147 Vascular endothelial cells prolong eosinophil survival-a novel mechanism for tissue eosinophilia? (1988) (0)
Extracellular Nucleotides and Histamine Suppress TLR3- and RIG-I–Mediated Release of Antiviral IFNs from Human Airway Epithelial Cells (2022) (0)
The genetic determinants of recurrent somatic mutations in 43,693 blood genomes (2023) (0)
Pharmacologic Aspects and Comparison with Human Lung Tissue Fragments14 (1982) (0)
Aspergillus Fumigatus Extract Suppresses the mRNA Expression of the IP-10 in Human Bronchial Epithelial Cells (2014) (0)
Session 3. Immune cells in allergic disorders (2004) (0)
Gastrointestinal Staphylococcus aureus: immune responses to its enterotoxins and regulatory T cell dysfunction in childhood food allergy: 267 (2019) (0)
Session 7. Treatment and prevention of asthma and allergic disorders (2004) (0)
Release of histamine from human leukocytes: Unique interaction of phorbol diester with other stimuli (1981) (0)
Elevated levels of β6 integrin and alpha smooth actin positive microparticles in nasal lavage fluid in chronic rhinosinusitis with nasal polyps: a potential biomarker of epithelial-mesenchymal transition in the pathophysiology of polyp recurrence (2018) (0)
Elevation Of Sputum Plasminogen Activator Inhibitor-1 Levels In The Subjects With Asthma (2011) (0)
Chairman's Remarks (2004) (0)
In vitro and in vivo induction of B7-H1 and B7-DC expression by human rhinovirus infection of airway epithelial cells (46.5) (2007) (0)
Glucocorticoid Budesonide C-C Chemokine Expression by IL-4 and the Differential Regulation of Epithelial-Derived (2013) (0)
Session 2. Genetic factors and immune tolerance in allergic disorders (2004) (0)
Inhibition of Lytic Programming by Pharmacologic Agents a, b (1988) (0)
Molecular Pathogenesis of Aspirin Intolerance (2014) (0)
The Role of Adhesion Molecules and Cytokines in Eosinophil Recruitment (2019) (0)
Age‐related B Cell Inflammatory Changes in Nasal Polyps: 864 (2019) (0)
In vitro and in vivo induction of B7-H1 and B7-DC expression by human rhinovirus infection of airway epithelial cells (2007) (0)
CRS‐PRO and SNOT‐22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis (2022) (0)
Cellular expression and activation of eosinophils and basophils by the C-C chemokine monocyte chemoattractant protein-4 (MCP-4). (1997) (0)
Regulation of Human Mast Cells by Fluticasone and Salmeterol (2007) (0)
SP418 – CRS in the setting of other chronic illnesses (2009) (0)
Inadequate Humoral Immunity in Patients with Chronic Rhinosinusitis (2010) (0)
Doctorate Program in Molecular Oncology and Endocrinology XVIII cycle-2002–2006 Coordinator: Prof. Giancarlo Vecchio “NOVEL MECHANISMS RESPONSIBLE FOR CONTROLLING GLUCOSE-INDUCED INSULIN SECRETION IN PANCREATIC BETA-CELLS” (2006) (0)
Detection of microparticles in nasal lavage fluid that express both integrin &bgr;6 and a marker of epithelial‐mesenchymal transition (either alpha‐smooth muscle actin or Snail) is useful for the identification of severe chronic rhinosinusitis: 642 (2019) (0)
Pathophysiologic Lessons: Studies from Aspirin Tolerant and Intolerant Rhinosinusitis with Nasal Polyps (2013) (0)
Identification of severe eosinophilic chronic rhinosinusitis based on eosinophil, mast cell and basophil microparticles in nasal lavage fluids (2021) (0)
INTERACTION BETWEEN THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR AND PDK 1 AS POTENTIAL THERAPEUTIC TARGET IN NEOPLASTIC CELLS ” (2007) (0)
Local Immunoglobulin Class Switch Recombination in Chronic Rhinosinusitis with Nasal Polyposis (2014) (0)
Adenosine receptor A2a inhibits complement-mediated activation of human mast cells by activating Gαs-proteins (139.5) (2009) (0)
Epithelium and Innate Immune Responses: Airways and Skin (2016) (0)
Analysis of Inflammatory Cytokines in Nasal Lavage Fluid (NLF) From Subjects with Chronic Rhinosinusitis (CRS) (2008) (0)
Naturally Occurring Tolerance Acquisition to Foods in Children Previously Allergic to Egg and Peanut Is Characterized By Antigen Specificity and Associated with Increased Subsets of Regulatory T Cells (2015) (0)
Expression of Glucocorticoid Receptor Translational Isoforms in Airway Epithelial and Monocytic Cells (2008) (0)
ANTIINFLAMMATORY STERIOD ACTION IN ALLERGIC DISEASES (1985) (0)
Opiates Activate Human Mast Cell Chemokine Production (2006) (0)
Microparticles in Nasal Lavage; Potential Biomarkers for Chronic Rhinosinusitis and Aspirin Exacerbated Respiratory Disease (2016) (0)
A Newly Established Murine Model of Nasal Polyps Demonstrates B Cell Activation, Similar to Human Nasal Polyps (2015) (0)
Defining the Cell Type through Which the Asthma-Associated Intercellular Junction Protein Alpha-T-Catenin Drives Asthma Phenotypes in Mice (2017) (0)
New Biological Therapies on the Horizon for Severe Allergic Diseases of the Airways and Skin (2016) (0)
Discussuion Session 4. 'Evergreen' mediators in asthma (2004) (0)
Radioimmunoassay for fentanyl. (1982) (0)
Subject Index Vol. 161, Suppl. 2, 2013 (2013) (0)
2018 AAAAI / WAO Joint Congress Y 1 Role of TNFSF 11 and Group 2 Innate Lymphoid Cells in Type 2 Inflammation in Chronic Rhinosinusitis with Nasal Polyps F R ID A (2018) (0)
airway obstruction in a subset of patients , and why reduction in FEV 1 is associated with a history of frequent exacerbations in asthmatic patients (0)
Blockade of Chemokine Production /Function as an Example of Glucocorticoid Anti-in.ammatory Actions (2001) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert P. Schleimer?

Robert P. Schleimer is affiliated with the following schools: